Contact Us    Downloads    Login 
   

              
 

Licensing

Increasingly, the corporate partnership or alliance has become the strategic linchpin for the healthcare industries. The costly and complex process of new product discovery and development requires the application of many diverse disciplines and technologies which often reside in multiple organizations. Through the extensive hands-on experience of the principals and its advisors, the Sage Group understands the strategy as well as the art of the deal. Bringing companies together in the process of adding strategic competitive value is one our greatest service priorities.

As a Sage Group client recently said, "The Sage Group is kind of like an investment banker, but you do more than they do."

The Sage Group invests in understanding its client, the company's goals, strengths, weaknesses, and "personalities." Sage matches these attributes with target companies where the goals of both can be achieved. Sage works closely in developing an offering document and presentation, and then works diligently to contact, explain, and screen target companies.

Sage then arranges for meetings, and continues to update, encourage, and stimulate a small group of highly interested targets. This creates a healthy, competitive environment within which Sage and the client's management, along with corporate counsel and other advisors, work to negotiate and consummate a transaction.

Good ideas, good technologies, promising compounds and good products only have value if they are able to find a market in a timely fashion, and preferably an efficient, cost-effective and value-realising route to market.

Sage has particular expertise in working with our clients to develop and license their technology and/or compounds in terms of both exploitation of intellectual property and identifying partners who can fund, develop and assist in enabling realisation of value and market entry.

Sage also has a strong network of industry contacts in US, EU and Japan who are continually seeking technology and pipeline compound opportunities. Conversely, we work in an ongoing manner with a number of clients whose technology is maturing rapidly and are seeking partners with whom they can collaborate.

Sage assists both groups of clients in identifying the optimum method of gaining value for their company and their technology through focused business development, an often challenging task for small- to medium-sized companies.
 



Oxford UK – 19th April 2010 – Sense Proteomic Ltd. has announced the appointment of The Sage Group as its business development consultant to assist in expanding its global biomarker discovery partnerships. Sense is part of Ox...Read entire article



Cambridge UK and Clinton USA – December 2009 – The Sage Group is pleased to announce the appointment of two new seasoned Executive Directors – Dr. Tom Geimer in Australia and Dr. Laurence Shaw in Israel. Drs. Geimer and...Read entire article



Cambridge UK and Clinton USA – December, 2009 – The Sage Group, Inc. is pleased to announce the expansion of its global network with the opening of an Israeli office and the appointment of Dr. Laurence Shaw as Executive Direc...Read entire article

Contact Us

If you are interested in contacting us or obtaining the contact details for one of our offices, please use our contact page.

If you would like to make a more comprehensive business enquiry, you can send us further details of your company using our Business Enquiry Form.

© The Sage Group 2008 Site by YouSoft   Privacy Policy   Contact us